AnaptysBio, Inc.ANABNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | 458.23% |
| Q3 2025 | 32.02% |
| Q2 2025 | -276.11% |
| Q1 2025 | 83.95% |
| Q4 2024 | -560.77% |
| Q3 2024 | 52.68% |
| Q2 2024 | 42.76% |
| Q1 2024 | -8.45% |
| Q4 2023 | 5.83% |
| Q3 2023 | -43.55% |
| Q2 2023 | -3.42% |
| Q1 2023 | -129.93% |
| Q4 2022 | 39.79% |
| Q3 2022 | 26.50% |
| Q2 2022 | -14.91% |
| Q1 2022 | 16.94% |
| Q4 2021 | -261.13% |
| Q3 2021 | -173.05% |
| Q2 2021 | 141.33% |
| Q1 2021 | -161.75% |
| Q4 2020 | 320.88% |
| Q3 2020 | 13.24% |
| Q2 2020 | -29.76% |
| Q1 2020 | 4.38% |
| Q4 2019 | 28.47% |
| Q3 2019 | -42.40% |
| Q2 2019 | 3.62% |
| Q1 2019 | -30.99% |
| Q4 2018 | 17.29% |
| Q3 2018 | -67.38% |
| Q2 2018 | 28.85% |
| Q1 2018 | -159.42% |
| Q4 2017 | -23.71% |
| Q3 2017 | -47.11% |
| Q2 2017 | 67.36% |
| Q1 2017 | -45.37% |
| Q4 2016 | -81.26% |
| Q3 2016 | -284.12% |
| Q2 2016 | 181.18% |
| Q1 2016 | 21.74% |